Explore the platform

Built around your practice.

Clinical care, daily operations and professional learning. Choose the tools that fit your pharmacy.

Explore all 9 modules Tap a module to preview it below.
The pharmacy briefing

News that matters to your practice.

All news
Regulatory Update

PEBC Ends the Pharmacist Evaluating Examination After October 2026; Alberta Sets a New Pathway for Internationally Educated Graduates

PEBC’s October 2026 sitting is the last Pharmacist Evaluating Examination; from January 2027, international pharmacy graduates with a valid document evaluation go straight to the Qualifying Examination Part I. Alberta has also replaced the CCPP bridging certificate with the University of Alberta’s Diploma in Canadian Pharmacy Practice for candidates who do not pass a qualifying exam part on the first attempt.

Read the briefing
Illustrative examination setting; not a PEBC examination. Alison wood / Wikimedia Commons, CC BY 3.0. Image source
Practice Guidance

Alberta College of Pharmacy: Confirm a Provider’s Authority Before Selling Schedule 1 Drugs for Office Use

After the College of Physicians & Surgeons of Alberta reported a man allegedly presenting himself as a physician in Edmonton without a practice permit since 2015, the Alberta College of Pharmacy reminded pharmacy teams on September 8, 2026 that Schedule 1 drugs for office use may only be sold once the provider’s authority to possess them is confirmed. The reminder applies to every community pharmacy that supplies clinic stock.

Read the briefing
Illustrative pharmacy dispensing; not a pharmacy or person involved. M Joko Apriyo Putro / Wikimedia Commons, CC BY-SA 4.0. Image source
Practice Guidance

NDSAC to Consider Schedule II Status for Epinephrine Nasal Spray at Its September 20 Meeting

NAPRA’s National Drug Scheduling Advisory Committee meets on September 20, 2026 to consider a request for Schedule II status for pre-filled epinephrine nasal spray devices used in anaphylaxis. If adopted by the provinces, community pharmacies would supply the device from behind the counter without a prescription.

Read the briefing
Illustrative nasal spray use; not the product under review. NIAID / Wikimedia Commons, CC BY 2.0. Image source

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.